Skip to main content

Table 1 Clinical characteristics between training and testing group

From: From genes to therapy: a lipid Metabolism-Related genetic risk model predicts HCC outcomes and enhances immunotherapy

Items

TCGA (n = 365)

ICGC (n = 232)

p Value

Age (years)

69.78 ± 30.87

67.72 ± 10.10

0.1018

Sex (male)

246

171

0.1015

Survival time (days)

811.9 ± 725.8171

811.9 ± 417.7

0.9998

Tumor stage

   

I

170

36

 

II

85

105

 

III

74

71

 

IV

4

19

< 0.0001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us